International, Multicenter, Randomized, Non-comparative Controlled Study of Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients With Long-term Viral Suppression.
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2013
At a glance
- Drugs Interleukin-7 (Primary) ; Maraviroc; Raltegravir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms ERAMUNE-01
- 10 Jun 2017 Biomarkers information updated
- 30 Jun 2013 Results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History